Clinical Trial Update: Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure [Phase 2]

View source ↗

Summary

This Phase 2 study evaluates lenalidomide in combination with dexamethasone for treating patients with multiple myeloma who have light-chain–induced renal insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Austrian Forum Against Cancer | Conditions: Multiple Myeloma Light Chain Induced Renal Insufficiency | Phase 2 | Status: UNKNOWN